Skip to main content
. 2016 Aug 12;50(4):415–423. doi: 10.1016/j.aott.2016.07.001

Table 3.

Treatment persistence for training and control groups in relation to weekly or monthly regimen.

Treatment persistence Training (n = 492) Control (n = 487) Total (979)
Duration (days) N Mean (SD) p value N Mean (SD) p value N Mean (SD) p value1
Overall 492 355.5 (94.6) 487 350.4 (101.1) 979 353.0 (97.8) 0.363
Weekly regimen 221 350.0 (106.0) 0.111 217 340 (109.0) 0.172 438 345.0 (108.0) 0.035
Monthly regimen
271
360.0 (84.0)

270
359 (94.0)

541
360.0 (89.0)


Left the study
Ongoing/Completed
p value
Left the study
Ongoing/Completed
p value
Left the study
Ongoing/Completed
p value
3rd month n (%) n (%) n (%) n (%) n (%) n (%)
Overall 64 (13.0) 428 (87.0) 58 (11.9) 429 (88.1) 122 (12.5) 857 (87.5) 0.565
Weekly regimen 38 (17.2) 183 (82.8) 0.016 27 (12.4) 190 (87.6) 0.836 65 (14.8) 373 (85.2) 0.058
Monthly regimen 17 (9.6) 245 (90.4) 31 (11.4) 239 (88.5) 57 (10.6) 484 (89.4)
6th month
Overall 93 (18.9) 399 (81.1) 90 (18.5) 397 (81.5) 183 (18.7) 796 (81.3) 0.744
Weekly regimen 50 (22.6) 171 (77.4) 0.082 39 (18.0) 178 (82.0) 0.647 89 (20.3) 349 (79.7) 0.351
Monthly regimen 43 (15.9) 228 (84.1) 51 (18.9) 219 (81.1) 94 (17.4) 447 (82.6)
9th month
Overall 109 (22.2) 383 (77.8) 116 (23.8) 371 (76.2) 225 (23.0) 754 (77.0) 0.583
Weekly regimen 51 (23.1) 170 (76.9) 0.957 54 (24.9) 163 (75.1) 0.929 105 (23.9) 333 (76.1) 0.921
Monthly regimen 58 (21.4) 213 (78.6) 62 (23.0) 208 (77.0) 120 (22.2) 421 (77.8)
12th month 102 (20.7) 390 (79.3) 100 (20.5) 387 (79.5) 202 (20.6) 777 (79.4) 0.939
Weekly regimen 57 (25.8) 164 (74.2) 0.012 51 (23.5) 166 (76.5) 0.146 108 (24.7) 330 (75.3) 0.005
Monthly regimen 45 (16.6) 226 (83.4) 49 (18.1) 221 (81.9) 94 (17.4) 447 (82.6)

Mann–Whitney U test 1 training vs. control.

Values in bold indicate statistical significance (p < 0.05).